Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $6.49 in the prior trading day, CryoPort Inc (NASDAQ: CYRX) closed at $6.17, down -4.86%. In other words, the price has decreased by -$4.86 from its previous closing price. On the day, 0.73 million shares were traded. CYRX stock price reached its highest trading level at $6.44 during the session, while it also had its lowest trading level at $5.98.
Ratios:
Our goal is to gain a better understanding of CYRX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.94 and its Current Ratio is at 5.29. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.57.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on December 19, 2024, initiated with a Buy rating and assigned the stock a target price of $11.
On August 07, 2024, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $20 to $8.
B. Riley Securities Upgraded its Neutral to Buy on July 31, 2024, whereas the target price for the stock was revised from $19 to $15.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 17 ’25 when ZECCHINI EDWARD J sold 1,140 shares for $6.29 per share. The transaction valued at 7,173 led to the insider holds 66,911 shares of the business.
STEFANOVICH ROBERT sold 1,659 shares of CYRX for $10,438 on Mar 17 ’25. The Chief Financial Officer now owns 191,419 shares after completing the transaction at $6.29 per share. On Mar 17 ’25, another insider, Sawicki Mark W, who serves as the Chief Scientific Officer of the company, sold 2,092 shares for $6.29 each. As a result, the insider received 13,162 and left with 85,436 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 323918208 and an Enterprise Value of 331176128. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.35 while its Price-to-Book (P/B) ratio in mrq is 0.79. Its current Enterprise Value per Revenue stands at 1.45 whereas that against EBITDA is -9.365.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.81, which has changed by -0.6150967 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $20.10, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is -12.31%, while the 200-Day Moving Average is calculated to be -20.95%.
Shares Statistics:
The stock has traded on average 359.78K shares per day over the past 3-months and 798860 shares per day over the last 10 days, according to various share statistics. A total of 49.91M shares are outstanding, with a floating share count of 48.12M. Insiders hold about 3.60% of the company’s shares, while institutions hold 95.75% stake in the company. Shares short for CYRX as of 1740700800 were 2046167 with a Short Ratio of 5.69, compared to 1738281600 on 2007584. Therefore, it implies a Short% of Shares Outstanding of 2046167 and a Short% of Float of 4.9200002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 2.0 analysts. The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.21 and low estimates of -$0.27.
Analysts are recommending an EPS of between -$0.84 and -$1.0 for the fiscal current year, implying an average EPS of -$0.92. EPS for the following year is -$0.9, with 2.0 analysts recommending between -$0.7 and -$1.11.
Revenue Estimates
7 analysts predict $57.97M in revenue for the current quarter. It ranges from a high estimate of $60.8M to a low estimate of $53.1M. As of the current estimate, CryoPort Inc’s year-ago sales were $54.59MFor the next quarter, 7 analysts are estimating revenue of $60.76M. There is a high estimate of $61.9M for the next quarter, whereas the lowest estimate is $58.8M.
A total of 8 analysts have provided revenue estimates for CYRX’s current fiscal year. The highest revenue estimate was $248M, while the lowest revenue estimate was $240M, resulting in an average revenue estimate of $244.36M. In the same quarter a year ago, actual revenue was $228.38MBased on 8 analysts’ estimates, the company’s revenue will be $265.14M in the next fiscal year. The high estimate is $270.9M and the low estimate is $260M.
